Hanna Hailu

机构：UCB Pharma (United Kingdom) · ORCID：0000-0001-6988-9977

发表论文 16 篇 · 总被引 1016 次 · h-index 11

代表论文

Methods for converting cysteine to dehydroalanine on peptides and proteins (2011 · Chemical Science · 被引 374)
Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration (2018 · mAbs · 被引 116)
Development of a therapeutic monoclonal antibody that targets secreted fatty acid–binding protein aP2 to treat type 2 diabetes (2015 · Science Translational Medicine · 被引 101)
A CHO cell line engineered to express XBP1 and ERO1‐Lα has increased levels of transient protein expression (2013 · Biotechnology Progress · 被引 97)
PDEPT: Polymer-Directed Enzyme Prodrug Therapy. 2. HPMA Copolymer-β-lactamase and HPMA Copolymer-C-Dox as a Model Combination (2003 · Bioconjugate Chemistry · 被引 94)
Human immunoglobulin E flexes between acutely bent and extended conformations (2014 · Nature Structural & Molecular Biology · 被引 66)